14-day Premium Trial Subscription Sign Up For FreeGet Free

aTyr Pharma Stock Forecast NASDAQ:LIFE

Price Target and Analyst Ratings

Most Recent Rating

On September 14, 2021 "Oppenheimer" gave "$14.00 - $20.00" rating for LIFE. The price target was set to $9.15+67.0%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-14 $14.00 - $20.00 Target Raised by Oppenheimer $9.00 $9.15+67.0%
2021-09-13 $13.00 - $18.00 Target Raised by HC Wainwright $9.15 $7.39+34.9%
2021-09-13 $20.00 - $21.00 Target Raised by Roth Capital $9.15 $10.11+84.5%
2021-06-30 Buy Reiterated by Jonestrading $4.88 $15.00
2021-05-24 Buy Initiated by Jonestrading $4.15 $15.00
2021-05-18 Buy Initiated by Jonestrading $3.96 $15.00
2021-05-18 Buy Initiated by Jonestrading $3.96
2021-05-10 Buy Initiated by Laidlaw $3.67 $18.00
2021-05-10 Buy Initiated by Laidlaw $3.67
2021-03-30 Outperform Target Raised by Oppenheimer $4.39 $12.00 → $14.00
2021-03-24 Buy Reiterated by Oppenheimer $4.66 $12.00 → $14.00
2021-03-24 Buy Reiterated by Oppenheimer $4.66 $14.00
2021-03-22 Buy Target Raised by Roth Capital $5.32 $15.00 → $20.00
2021-03-16 Positive - Buy Target Raised by Roth Capital $6.14 $15.00 → $20.00
2020-09-22 Buy Reiterated by Oppenheimer $3.89
2020-08-17 Neutral - Buy Upgraded by HC Wainwright $4.17 $13.00
2020-06-16 Buy Reiterated by Oppenheimer $3.83 $8.00
2020-05-13 Buy Reiterated by Oppenheimer $3.71 $8.00
2020-04-21 Hold Reiterated by HC Wainwright $3.25

LIFE Stock Trend

Given the current short-term trend, the stock is expected to rise 28.25% during the next 3 months and, with a 90% probability hold a price between $7.34 and $13.16 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $5.76 $8.03 $10.30
2021-09-21 $5.80 $8.07 $10.33
2021-09-22 $5.83 $8.10 $10.37
2021-09-23 $5.87 $8.14 $10.40
2021-09-24 $5.91 $8.17 $10.44
2021-09-27 $5.94 $8.21 $10.48
2021-09-28 $5.98 $8.24 $10.51
2021-09-29 $6.01 $8.28 $10.55
2021-09-30 $6.05 $8.32 $10.58
2021-10-01 $6.09 $8.35 $10.62
2021-10-04 $6.12 $8.39 $10.65
2021-10-05 $6.16 $8.42 $10.69
2021-10-06 $6.19 $8.46 $10.73
2021-10-07 $6.23 $8.50 $10.76
2021-10-08 $6.26 $8.53 $10.80
2021-10-11 $6.30 $8.57 $10.83
2021-10-12 $6.34 $8.60 $10.87
2021-10-13 $6.37 $8.64 $10.91
2021-10-14 $6.41 $8.67 $10.94
2021-10-15 $6.44 $8.71 $10.98
2021-10-18 $6.48 $8.75 $11.01
2021-10-19 $6.52 $8.78 $11.05
2021-10-20 $6.55 $8.82 $11.09
2021-10-21 $6.59 $8.85 $11.12
2021-10-22 $6.62 $8.89 $11.16
2021-10-25 $6.66 $8.93 $11.19
2021-10-26 $6.70 $8.96 $11.23
2021-10-27 $6.73 $9.00 $11.26
2021-10-28 $6.77 $9.03 $11.30
2021-10-29 $6.80 $9.07 $11.34

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-gir... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT